inspect molecule / yupelri
Yupelri
Revefenacin ___ /___\ || breath
Revefenacin is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.
active moietyRevefenacin
administration routeRespiratory (Inhalation)
price comparison status2 snapshots
safety signal rating54 / 100
Anticholinergic [EPC]openFDA NDC seedopenFDA NDC175 ug/3mL
price index
Typical Class Estimates
⚠ Verified price snapshots are queued for this brand/package. Showing typical market estimates based on the drug class: Anticholinergic [EPC].
$24.50USvsCA$14.20CA
- US Typical Class Average · US$24.50
30 tablets · acquisition-reference · Molecule Index Class Benchmark ↗
- CA Typical Class Average · CACA$14.20
30 tablets · formulary-benefit-price · Molecule Index Class Benchmark ↗
Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.
query trend --id 2649 --12m
Price Trend Index
Deterministic trailing 12-month value delta index for this active ingredient class.
Rising Fast3M: +1.7%12M: +6.4%
Jul 2025Jun 2026
Jan 2026$23.86
Feb 2026$23.89
Mar 2026$24.08
Apr 2026$24.28
May 2026$24.30
Jun 2026$24.50
01 / chemistryViatris Specialty LLC
Ingredient Breakdown
active moietyRevefenacin
formulationRespiratory (Inhalation) Anticholinergic [EPC]
mechanism of action
Anticholinergic [EPC]
available strengths
175 ug/3mL
02 / ingredientsexcipients
Excipients / Maker Notes
- Not enriched yet from label source.
Manufacturer Notes
- This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals
Steps To Take Safely
- Confirm the ingredient and whether the inhaler is rescue, maintenance, or both.
- Check priming, spacer, cleaning, and puff-count instructions before first use.
- Log frequency of use; high rescue use can be a clinical signal, not just a price issue.
- Seek urgent care for severe wheeze, blue lips, confusion, or symptoms not relieved as directed.
Side-Effect Signals
- label-specific reactions
- allergic reaction
- interaction risk
- dose/formulation confusion
- urgent symptoms require clinician review
Summary of index signals. Not active medical advice. Consult official labels and clinicians.
$ grep ingredient --same
Same Ingredient Sibling Records
No same-ingredient sibling appears in the current indexed records yet.